Nicoretteskin (Nicotine)

Nicoretteskin, a nicotine replacement therapy, is used in the management of nicotine dependence.

• Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while quitting.
• Tobacco dependence: provides a steady nicotine supply to support gradual reduction of use.
• Relapse prevention: assists individuals who have quit smoking to maintain abstinence and avoid relapse.

• Nicotine in Nicoretteskin binds to nicotinic acetylcholine receptors (nAChRs), especially the α4β2 subtype, in the central nervous system. This agonist activity mimics the effect of tobacco‑derived nicotine, maintaining basal cholinergic stimulation and thereby reducing the intensity of withdrawal and craving. The transdermal system delivers nicotine continuously, avoiding rapid plasma peaks and facilitating a smoother tapering of dependence.

Common and serious adverse reactions may occur with Nicoretteskin use.

Common Side Effects

• Skin irritation: redness, itching, or mild rash at the application site.
• Burning sensation: localized warmth or tingling where the patch is placed.
• Headache: mild to moderate headache during the initial days of therapy.
• Nausea: occasional feeling of queasiness or upset stomach.

Serious or Rare Side Effects

• Allergic reaction: hives, swelling, or severe rash indicating hypersensitivity.
• Severe skin dermatitis: extensive blistering or ulceration at the patch site.
• Dizziness or fainting: sudden light‑headedness that may lead to falls.
• Chest pain: unexplained thoracic discomfort requiring immediate medical evaluation.

Before using Nicoretteskin, consider the following precautions to ensure safe and effective therapy.

• Cardiovascular assessment: evaluate history of heart disease, as nicotine may increase heart rate and blood pressure.
• Recent myocardial infarction: avoid use within the first few weeks after a heart attack.
• Non‑smokers: do not use the patch if you are not a regular tobacco user.
• Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent overdose.
• Pediatric safety: keep patches out of reach of children and pets to avoid accidental exposure.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicoretteskin may interact with other medicines; awareness of these interactions helps minimize risk.

Major Interactions (Avoid)

• Other nicotine products: using nicotine gum, lozenges, or e‑cigarettes can cause nicotine excess.
• Monoamine oxidase inhibitors (MAOIs): concurrent use may increase cardiovascular effects of nicotine.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., methoxsalen): may reduce nicotine metabolism, raising plasma levels.
• Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring monitoring.
• Certain antidepressants (e.g., bupropion): may enhance stimulant effects and affect sleep.